Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi by Krautkrämer, Ellen et al.
CASE REPORT Open Access
Clinical characterization of two severe cases
of hemorrhagic fever with renal syndrome
(HFRS) caused by hantaviruses Puumala
and Dobrava-Belgrade genotype Sochi
Ellen Krautkrämer1*, Christian Nusshag1, Alexandra Baumann1, Julia Schäfer1, Jörg Hofmann2, Paul Schnitzler3,
Boris Klempa2,4, Peter T. Witkowski2, Detlev H. Krüger2 and Martin Zeier1
Abstract
Background: Hantavirus disease belongs to the emerging infections. The clinical picture and severity of infections
differ between hantavirus species and may even vary between hantavirus genotypes. The mechanisms that lead to
the broad variance of severity in infected patients are not completely understood. Host- and virus-specific factors
are considered.
Case presentation: We analyzed severe cases of hantavirus disease in two young women. The first case was
caused by Puumala virus (PUUV) infection in Germany; the second case describes the infection with Dobrava-
Belgrade virus (DOBV) in Russia. Symptoms, laboratory parameters and cytokine levels were analyzed and
compared between the two patients. Serological and sequence analysis revealed that PUUV was the infecting
agent for the German patient and the infection of the Russian patient was caused by Dobrava-Belgrade virus
genotype Sochi (DOBV-Sochi). The symptoms in the initial phase of the diseases did not differ noticeably
between both patients. However, deterioration of laboratory parameter values was prolonged and stronger in
DOBV-Sochi than in PUUV infection. Circulating endothelial progenitor cells (cEPCs), known to be responsible for
endothelial repair, were mobilized in both infections. Striking differences were observed in the temporal course
and level of cytokine upregulation. Levels of angiopoietin-2 (Ang-2), vascular endothelial growth factor (VEGF),
and stromal derived factor-1 (SDF-1α) were increased in both infections; but, sustained and more pronounced
elevation was observed in DOBV-Sochi infection.
Conclusions: Severe hantavirus disease caused by different hantavirus species did not differ in the general
symptoms and clinical characteristics. However, we observed a prolonged clinical course and a late and
enhanced mobilization of cytokines in DOBV-Sochi infection. The differences in cytokine deregulation may
contribute to the observed variation in the clinical course.
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Background
Diseases caused by hantaviruses differ enormously in
severity and clinical course. Host- and virus-specific de-
terminants are discussed as reasons for the broad range
of clinical pictures [1–5]. The most obvious differences
exist between the clinical picture of hantaviral cardiopul-
monary syndrome (HCPS) and HFRS caused by New and
Old World hantaviruses, respectively [6]. Whereas HCPS
manifests predominantly in the lung, HFRS is mostly
characterized by renal failure. However, there is also a
broad variety of symptoms in hantavirus disease caused
by Old World hantaviruses. In contrast to Hantaan
virus (HTNV), infection with PUUV is associated in
most cases with a mild form of HFRS. Various geno-
types exist within the species Dobrava-Belgrade virus
and they cause diseases of different severity [7]. In
addition, hantavirus infection exhibits individual differ-
ences ranging from subclinical to fatal outcome.
The reasons for the variation of severity between
virus species/genotypes and in individual patients are
not yet known. Diverse determinants concerning virus-
and patient-specific characteristics may play a role in
the pathogenesis. Differences in the use of entry recep-
tors, in the regulation of cytokine response and in viral
replication were described to be associated with pathogen-
icity [8–11]. Studies with genetic reassortants in vitro and
in animal models suggest molecular determinants to be
responsible for virulence [5, 12]. However, the species-
specific factors of hantaviruses that are responsible for
pathogenicity and clinical picture are not identified so
far. Interestingly, the pathogenicity of related viruses of
DOBV genotypes differs enormously with case fatality
rates (CFRs) between 0.3%-0.9% for DOBV genotype
Kurkino and 14.5% for DOBV genotype Sochi [13]. In
addition to severe courses that are linked to specific
virus species or genotypes, several serious cases were
reported for infection with PUUV that usually causes a
milder form of hantavirus disease [14, 15]. These infec-
tions often involve extrarenal manifestations [16, 17].
Severe cases caused by various hantavirus species are not
well characterized with regard to their differences and
similarities in symptoms, organ involvement, laboratory
parameters, and clinical course.
The comparison of the clinical picture and course of se-
vere disease caused by different hantavirus species may
provide useful insights into their pathogenicity. Therefore,
we analyzed the course of two severe hantavirus cases
caused by infection with PUUV and DOBV-Sochi.
Case presentation
We report on hantavirus disease of a 25-year old German
and a 20-year-old Russian woman infected with hantavirus
PUUV and DOBV, respectively. Patients infected with
hantavirus PUUV and DOBV were hospitalized in the
Department of Nephrology, University of Heidelberg,
Germany, in 2012 and 2014, respectively. The infection
with DOBV occurred in the district of Krasnodar, South
Russia, and the one with PUUV in Heidelberg, Germany.
Infection was diagnosed by positive IgG and IgM hanta-
viral serology (recomLine HantaPlus assay, Mikrogen
Diagnostik). Admission was on day four and on day six
after onset of symptoms for the patient with PUUV and
DOBV infection, respectively. To analyze the genotype
of DOBV and to obtain partial nucleotide sequences of
genomic segments, RT-PCR of serum and urine samples
with subsequent sequencing was performed as described
previously [18, 19]. Hantaviral RNA was detected in serum
but not in urine. Partial nucleotide sequences of S, M,
and L segments amplified from serum derived from the
DOBV-Sochi patient were deposited in GenBank (acces-
sion numbers KU529946, KU529944 and KU529945). The
sequences showed high similarity to DOBV-Sochi se-
quences obtained from Black Sea field mice (Apodemus
ponticus) and from a fatal case of hantavirus disease re-
ported in a 47-year-old woman in the district of Krasno-
dar in southern European Russia (Table 1) [13, 20, 21]. No
pre-existing conditions, such as renal, pulmonary or car-
diovascular disease, diabetes mellitus, hypertension or
obesity, were found. Body weight and height were similar
between the patients. Both patients were non-smokers.
Symptoms during the early phase of both cases were very
similar (Table 2). Both cases showed the typical initial
signs of hantavirus infection: Sudden onset of fever and
flu-like symptoms. However, the course of DOBV infec-
tion resulted in a rapid decline of general condition and
required admission to intensive care unit on day eight
after onset of symptoms because of progressive respiratory
problems with beginning hypoxia. The maximal and min-
imal levels of laboratory parameters differed between
PUUV and DOBV-Sochi disease (Table 3). It is to note
that the absolute peak and nadir levels probably occurred
before admission. Thereby, the impairment of laboratory
parameter levels may be underestimated particularly with
Table 1 Nucleotide (nt) and amino acid (aa) sequence identities
(%) of partial DOBV-Sochi sequences
S segment M segment L segment
Virus isolatea nt aa nt aa nt aa
Sochi/hu 98.6 98.4 97.4 98.9 98.6 100.0
Sochi/Ap 98.8 98.9 97.4 98.9 n.a.b n.a.
10645/Ap 98.6 98.9 n.a. n.a. 99.4 100.0
aSequences were amplified from serum sample of our DOBV-Sochi (2014)
infected patient and compared to published sequences of DOBV-Sochi strains
isolated from human (hu) and Apodemus ponticus (Ap). Accession numbers for
nucleotide and amino acid sequences: Sochi/hu (S, M, L segment): JF920150,
JF920149, JF920148 and AES92929, AES92928, AES92927; Sochi/Ap (S, M
segment): EU188449, EU188450 and ABY64966, ABY64967; 10645/Ap (S, L
segment): KP878312, KP878309 and ALP44173, ALP44170
bn.a not available
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regard to DOBV-Sochi infection because the admission
occurred two days later compared to the PUUV-
infected patient. We observed elevated levels of lipase
and P-amylase in the patient infected with DOBV-
Sochi, indicating a possible hantavirus-related acute
pancreatitis. The association of HFRS with acute pan-
creatitis was described for several cases of infection
with Dobrava-Belgrade and Hantaan virus [22–24], but
not for infections with Puumala virus [25].
Urine analysis revealed proteinuria and the presence of
erythrocytes and leukocytes in the urine with higher cell
counts for erythrocytes (43 cells/μl versus 561 cells/μl)
and leukocytes (6 cells/μl versus 34 cells/μl) in the pa-
tient with DOBV-Sochi. Apart from these characteristic
urine pathologies, both patients developed uremia and
oliguria. Glucosuria, pollakiuria, nycturia or dysuria were
not observed. Lastly, they suffered from anuria in the fur-
ther clinical course. As a consequence, renal replacement
therapies were applied. The reasons for dialysis were
uremia and severe fluid overload for DOBV-Sochi patient
and uremia for PUUV patient. The patient infected with
PUUV infection was dialyzed once on day seven after on-
set of symptoms, whereas the patient with DOBV-Sochi
infection underwent dialysis six times between day nine
and day 18 after onset of symptoms (Fig. 1). With excep-
tion of scleral bleeding and petechiae in the patient with
DOBV-Sochi infection, no bleedings, such as epistaxis,
hematoma, melena or hematochezia, were observed in the
two patients. Symptoms of involvement of the respiratory
tract were cough in the case of PUUV infection, pleural
effusion and pulmonary congestion in the DOBV-Sochi
patient (Fig. 2). The patient with DOBV-Sochi presented
with tachycardia. No other cardiovascular or other extra-
renal organ manifestations were observed. Patients did
neither exhibit ophthalmological symptoms nor complica-
tions of the CNS.
The analysis of the course of laboratory parameters in
DOBV-Sochi infection demonstrated a prolonged phase
with elevated levels of leukocytes and serum creatinine
and decreased levels of thrombocytes and serum albumin
compared to infection with PUUV (Fig. 1). Several param-
eters, e.g. thrombocytopenia, have been described to be
associated and predictive for severe courses of hantavirus
Table 2 Characteristics and symptoms of two patients infected
with PUUV and DOBV-Sochi
PUUV DOBV-Sochi
Age (years) 25 20
Body weight change (kg) 0.8 10
BMIa at discharge 18.4 18.5
Hospitalization (days) 9 18
Intensive care unit stay (days) 0 2
Maximum temperature (°C) 39.6 40.0
Headache n.d.b +
Abdominal pain + +
Back-/side pain + -
Myalgia n.d. +
Pain in the limbs n.d. +
Nausea + +
Vomiting + +
Diarrhea - +
Obstipation + -
Night sweats - -
Dyspnea - +
Cough + -
Pleural effusion - +
Pulmonary congestion - +
Pulmonary edema - -
Infiltrates - -
Vertigo + -
Petechiae - +
Edema - +
Ascites + -
Hyperkalemia + +
Dialysis (number) + (1) + (6)
aBMI body mass index, bn.d not determined
Table 3 Maximum and minimum levels of laboratory parameters
of two patients with hantavirus infection
PUUV DOBV-Sochi Reference values
Serum creatinine (mg/dL) 10.89 9.34 0.1–1.3
Urea (mg/dL) 120 231 <45
Uric acid (mg/dL) 6.5 11 <6
Serum albumin (g/L) 31.1 27.2 30–50
CRP (mg/L)a 61.2 101.5 <5
LDH (U/L)b 422 553 <248
Lipase (U/L) 24 860 <51
P-amylase (U/L) 25 520 8–53
Bilirubin total (mg/dL) 0.9 0.9 <1.0
GPT (U/L)c 59 55 <35
GOT (U/L)d 66 87 <35
γ-GT (U/L)e 77 81 <40
Alkaline phosphatase (U/L) 90 129 55-105
Hemoglobin (g/dL) 11 8.2 12–15
Hematocrit (L/L) 0.31 0.25 0.36–0.47
Platelets (109/L) 51 53 150–440
Leukocytes (109/L) 7.57 13.07 4–10
aCRP C-reactive protein, bLDH lactate dehydrogenase, cGPT glutamate pyruvate
transaminase, dGOT glutamate oxalacetate transaminase, eγ-GT γ
-glutamyl transferase
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disease [26–28]. A low platelet count (<60 × 109/L) indi-
cates a subsequent acute renal failure with a rise in serum
creatinine levels in Puumala virus infection [27, 29].
Corresponding to this definition for severe cases of PUUV
infection, we observed platelet level of 51 × 109/L for the
patient with PUUV infection. For the DOBV-Sochi patient
the level (53 × 109/L) was also below 60 × 109/L on
admission.
The hospitalization of the patient with PUUV infection
lasted nine days, whereas the patient with DOBV-Sochi
infection was hospitalized for 18 days. The outcome of
the hantavirus infection of both patients was complete
recovery of renal function.
Our previous studies revealed the role of circulating
endothelial progenitor cells (cEPCs) and cEPCs-mobilizing
cytokines in the clinical course of patients infected with
PUUV [30]. As the normalization of laboratory parameters
is paralleled to the mobilization of cEPCs, we analyzed the
levels of cEPCs and of cEPC-mobilizing cytokines in the
patients (Fig. 3). Quantification of levels of cEPCs by flow
cytometry and of cytokines by Quantikine enzyme-linked
immunosorbent assay (ELISA; R&D Systems) of patients
and of 23 healthy persons was performed as described
previously [30].
Both patients demonstrated an increase in levels of
cEPCs, Ang-2, VEGF, and SDF-1α compared to levels
Fig. 1 Course of laboratory parameters in patients infected with DOBV-Sochi and PUUV. Black and gray arrowheads indicate dialysis in PUUV and
DOBV-Sochi patient, respectively. dpo, days post onset
Fig. 2 Chest x-ray of patients infected with PUUV (a, admission) and DOBV-Sochi (b, admission, bedside chest x-ray; c, after renal replacement
therapy, 12 dpo)
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observed in healthy controls. Erythropoietin (EPO) levels
were decreased during the disease indicating damage to
the EPO-producing renal cells. All four samples of the
PUUV patient and the samples of day 16 and 21 of the
DOBV-Sochi patient were below detection limit of the
EPO assay (<2.5 mIU/ml). Besides the varying extent of
cytokine level elevation, differences existed in the course
of cEPC and cytokine level changes between both infec-
tions. A prolonged elevation of cEPC levels with a slow
normalization in the patient with DOBV-Sochi infection
was observed. The duration of the increase of Ang-2 and
SDF-1α levels was also extended and much higher in
DOBV-Sochi infection than in infection with PUUV.
Furthermore, levels of VEGF in DOBV-Sochi infection
increased later than in PUUV infection. The same delay
was observed for the decrease of EPO levels. Taken to-
gether, both infections are characterized by mobilization
of cEPCs and cytokine level elevation, but the temporal
course and the extent of increase of cytokine levels differ
enormously between infection with PUUV and DOBV-
Sochi.
Conclusions
Among Old World hantaviruses, DOBV genotype Sochi
is characterized by severe clinical course and a high
CFR of 14.5% [13]. In contrast, PUUV disease exhibits
a low CFR of less than 1% [31]. However, diseases
caused by DOBV-Sochi and PUUV infection may also
differ individually and cases of severe hantavirus disease
due to PUUV infection were reported [14, 32, 33]. We
compared two severe hantavirus infections caused by
these two different virus species, PUUV and DOBV-
Sochi. The two cases did not differ significantly with re-
gard to symptoms and organ involvement. However, the
DOBV-Sochi infection presented with an enhanced im-
pairment of laboratory parameters and a prolonged renal
phase. The more severe clinical picture of infection with
DOBV compared to PUUV corresponds to the observa-
tions made in other studies that compared infections with
PUUV and different DOBV genotypes. Patients with
DOBV infections were more often hypotensive, exhibited
higher levels of serum creatinine, displayed more severe
thrombocytopenia and required dialysis more often
compared to patients infected with PUUV [34–36]. Our
analysis of the clinical course of the two infections re-
vealed further differences between the two infections.
Impairment of laboratory parameters and upregulation
of cytokines were prolonged in DOBV-Sochi infection.
Fig. 3 Course of cEPC numbers and plasma cytokine levels during
hantavirus infection with DOBV-Sochi and PUUV. Horizontal dashed
lines indicate the mean levels of 23 healthy control persons. EPO
levels of some patient samples were below the limit of detection of
the assay (<2.5 mIU/ml, horizontal line)
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The mechanisms that are responsible for the more se-
vere and protracted course of DOBV-Sochi infection
are not completely understood. Previous studies have
demonstrated a role of endothelial activation and repair
in the clinical course of PUUV infection [30, 37]. The
normalization of clinical parameters has been paralleled
to the mobilization of endothelial progenitor cells. We
also observed a mobilization of cEPCs in these two
hantavirus infected patients. Similar to the observations
for PUUV infection, levels of cEPCs and mobilizing
cytokines were elevated in DOBV-Sochi infections.
However, the increase of cytokines started later after
onset of symptoms and was higher in infection with
DOBV-Sochi than in PUUV infection.
Different cytokines were discussed to be responsible for
hantavirus pathogenesis [9, 38–41]. Several studies ana-
lyzed the role of VEGF in hantavirus disease [30, 42–45].
The effect of VEGF seems to be temporally regulated.
Early and localized upregulation of VEGF may be respon-
sible for the clinical symptoms such as capillary leakage
during hantavirus infection. In contrast, late and systemic
elevation of VEGF may contribute to endothelial repair.
As shown for VEGF, Ang-2 may also contribute to the
pathogenesis of hantavirus disease. Altered ratios between
angiopoietin-1 and −2 impair the barrier function of the
endothelial monolayer during Dengue virus infection [46].
The levels of Ang-2 were much higher in the patient with
DOBV-Sochi infection than in the one with PUUV.
A reason for the altered clinical course and cytokine
deregulation of DOBV-Sochi infection may be the en-
hanced replication of the virus. Viral load and antibody
response influence the severity and the clinical course of
hantavirus infection [47–49]. Unfortunately, we could
neither measure the titer of hantaviral genomes nor of
hantavirus-specific antibodies to explore a possible asso-
ciation between clinical course and viral titer or antibody
response in our patients. It would be of interest to
analyze if the differences observed in these two cases are
specific for DOBV-Sochi infections compared to PUUV
infections in a larger cohort of patients. The comparison
of the clinical course of hantavirus genotypes with differ-
ent pathogenicity may help to explore the underlying
mechanisms. It seems that the infections were very
similar in symptoms and induce the same pathways of
cytokine signaling and endothelial damage and repair.
However, research should further focus on the observed
differences in the kinetics of cytokine mobilization. As
observed for VEGF in hantavirus infection, cytokines
may have detrimental as well as beneficial effects during
the clinical course. Therefore, the knowledge about the
role of cytokines in the clinical course and its temporos-
patial regulation in infections with different pathogenic
hantavirus is crucial for the development of therapeutic
strategies interfering with cytokine signaling.
The comparison of hantavirus disease caused by in-
fection with PUUV and DOBV-Sochi revealed a more
severe course for DOBV-Sochi. Initial symptoms and
organ involvement did not vary noticeably. The two in-
fections differed especially in the course and levels of
cytokine upregulation. These results may indicate that
temporal control and high level upregulation of certain
cytokines contribute to the severity of the clinical
course of hantavirus disease.
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